Wednesday, October 22, 2008 |
Plenary Session: Clinical Priorities |
1:00 pm – |
1:30 pm |
Welcome and Opening Remarks
Susan B. Shurin, M.D.
Deputy Director, NHBLI, and Acting Division Director
Division of Blood Diseases and Resources
Willarda V. Edwards, M.D., M.B.A.
President and Chief Operating Officer
Sickle Cell Disease Association of America
Kwaku Ohene-Frempong, M.D.
Professor of Pediatrics
University of Pennsylvania School of Medicine
Barbara Alving, M.D.
Director
National Center for Research Resources |
1:30 pm |
|
New Ways of Looking at Clinical Research
Barbara Alving, M.D.
Director
National Center for Research Resources
|
1:45 pm – |
3:45 pm |
Reports from Sub-Committees on High-Priority Clinical Research
- Pulmonary/Cardiac Complications
Co-chairs:
Johnson Haynes, M.D., University of South Alabama
Mark T. Gladwin, M.D., University of Pittsburgh
- Renal Complications
Co-chairs:
Scott D. Miller, M.D., SUNY Downstate Medical Center
Jon Scheinmann, M.D., University of Kansas School of Medicine
- Transplantation
Co-chairs:
Mark C. Walters, M.D., Children's Hospital Oakland Research Institute
John E. Levine, M.D., University of Michigan
|
3:45 pm – |
4:00 pm |
Break |
4:00 pm – |
6:15 pm |
Continue Reports from Sub-Committees on High-Priority Clinical Research
- Pain
Co-chairs: Wally Smith, M.D., Virginia Commonwealth University Sean Mackey, M.D., Ph.D., Stanford School of Medicine
- Epidemiology/Patient Outcomes
Co-chairs: Ellie Schoenbaum, M.D., Albert Einstein College of Medicine Kevin Schulman, M.D., Duke University
- Fetal Hemoglobin
Co-chairs: Alan Schechter, M.D., National Institute of Diabetes and Digestive and Kidney Diseases George J. Dover, M.D., Johns Hopkins University
- Neurology
Co-chairs: Robert J. Adams, M.D., Medical University of South Carolina Russell E. Ware, M.D., Ph.D., St. Jude Children's Research Hospital
- Vascular Biology/Pathophysiology
Co-chairs: Barry Coller, M.D., Rockefeller University Roy L. Silverstein, M.D., Cleveland Clinic
|
6:15 pm |
|
Summary |
6:30 pm |
|
Adjournment |
|
|
|
Thursday, October 23, 2008 |
|
|
|
8:30 am – |
11:30 am |
Breakouts
- Pulmonary/Cardiac Complications
- Renal Complications
- Transplantation
- Pain
- Epidemiology/Patient Outcomes
- Fetal Hemoglobin
- Neurology
- Vascular Biology/Pathophysiology
|
11:30 am – |
1:00 pm |
Lunch (on your own) |
1:00 pm – |
4:30 pm |
Reports from Morning Breakouts |
4:30 pm – |
6:00 pm |
Keynote Address: Building Networks: Observations From Oncology and Non-Medical Industries
David Dilts, Ph.D., M.B.A.
Director, Center for Management Research in Healthcare
Professor of Operations Management
Director, Engineering Management Program
School of Engineering
Vanderbilt University |
|
|
|
Friday, October 24, 2008 |
Plenary Session: Creating the Infrastructure for Clinical Trials: Lessons Learned and Future Plans |
8:30 am – |
9:00 am |
Attributes of an Optimal Clinical Trials Framework for Sickle Cell Disease
Kathryn Hassell, M.D. Colorado Sickle Cell Center and NHLBI Division of Blood Diseases and Resources |
9:00 am – |
9:30 am |
Report from Sickle Cell Disease Task Force (ASPHO Summit)
Clinton Joiner, M.D., Ph.D.
Cincinnati Children's Hospital Medical Center |
9:30 am – |
10:00 am |
Lessons Learned: Clinical Trials in Oncology
Judith Manola, M.S. Dana-Farber Cancer Institute |
10:00 am – |
10:30 am |
Lessons Learned: Clinical Trials in HIV/AIDS
James Neaton, Ph.D.
University of Minnesota |
10:30 am – |
11:00 am |
Lessons Learned: Clinical Trials in Asthma
Gail Weinmann, M.D. Division of Lung Diseases, National Heart, Lung, and Blood Institute |
11:00 am – |
12:00 pm |
Comments from the SCD Community |
12:00 pm |
|
Summary and Next Steps
Susan B. Shurin, M.D.
Deputy Director, National Heart, Lung, and Blood Institute and
Acting Division Director, Division of Blood Diseases and Resources
|
12:15 pm |
|
Adjournment |